Energy balance
Adipose-specific overexpression of UCP1 via hADP promoter-modified plasmids induces thermogenesis and energy expenditure, leading to significant fat mass loss without lean mass loss in obese mice.
This research suggests that stimulating fat tissue to burn energy (thermogenesis) via a specific gene therapy could reduce fat mass without losing muscle. While promising in mice, this is not yet a human treatment. The key takeaway is that targeting energy expenditure in fat cells is a viable strategy for obesity, potentially avoiding the gut side effects of current drugs like GLP-1 agonists.
In obese mice, administration of the hADP-Ucp1 OE plasmids resulted in significant weight loss and improved metabolic homeostasis... hADP-Ucp1 OE plasmid treatment resulted in a significant decrease in fat mass, while no loss of lean mass was observed.
Why this rating
High-quality animal model data with robust statistical power, but lacks human clinical trials.
Source
DNA‐mediated UCP1 overexpression in adipose tissue: A promising anti‐obesity gene therapy
Zewei Zhao et al. · Clinical and Translational Medicine · 2025
DOI 10.1002/ctm2.70491
Related findings · Energy balance
- Achieving a total body weight loss of 10-15% (or >10-15 kg) through Total Diet Replacement (TDR) induces remission of Type 2 Diabetes in individuals with short-duration disease.Strong
- Bariatric surgery is superior to medical management alone for inducing significant long-term weight loss, remission of type 2 diabetes, and reduction in mortality for patients with BMI ≥ 40 or ≥ 35 with comorbidities.Strong
- Achieving type 2 diabetes remission requires significant weight loss (≥15 kg) via major caloric restriction, independent of macronutrient composition.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →